Mirae Asset Global Investments Co., Ltd. Nuvalent, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Nuvalent, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,765 shares of NUVL stock, worth $149,954. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,765
Previous 13,911
87.31%
Holding current value
$149,954
Previous $1.04 Million
87.26%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding NUVL
# of Institutions
178Shares Held
56.6MCall Options Held
527KPut Options Held
131K-
Deerfield Management Company, L.P. (Series C) New York, NY20MShares$1.7 Billion31.83% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY4.57MShares$388 Million14.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.78MShares$321 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.02MShares$257 Million0.01% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA2.7MShares$229 Million41.86% of portfolio
About Nuvalent, Inc.
- Ticker NUVL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,977,800
- Market Cap $3.65B
- Description
- Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...